Athens supports regulatory obligation for pricing and reimbursement, to ensure medicines access [Advocacy Lab Content]

Talks around the 'incentives-cluster' within the EU's pharma legislation remain wide open, with Athens supporting the so-called 'delinked option', says Aris Angelis, Secretary General for Strategic Planning of the Greek health ministry.